Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
- Extension Increases Total Addressable Market to Include Both Conventional Non-Amplifying mRNA and saRNA -- Extension Enabled by the Company's...
Day: November 16, 2023
Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion
LAS VEGAS, NV / ACCESSWIRE / November 16, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), f/k/a Odyssey Group International, Inc., a...
Revolutionizing Regtech: LighthouseAI Secures Strategic Investment and Landmark Law Firm Partnership
LighthouseAI Set to Impact the Regulatory Technology Industry with AI-driven ComplianceLOS ANGELES, CA / ACCESSWIRE / November 16, 2023 /...
REMORY, a Supplement Known for Containing Plasmalogens, Which Are Recognized for Their Role in Preventing Cognitive Decline, Now Available in the United States
REMORY: Elevate Cognitive Health with Unique Sea Squirt-Derived Plasmalogens. Now in the U.S., this Japanese-Innovated Supplement Combines EPA, DHA, and...
Laxxon Medical joins German Accelerator’s Southeast Asia Market Access Class of 2023, marking the Company’s inaugural globalization venture
NEW YORK, NY / ACCESSWIRE / November 16, 2023 / Pharmaceutical 3D screen printing company Laxxon Medical has been selected...
NLS Pharmaceutics Announces Selection of Strategic Partner and Securing a Bridge Loan
NLS has executed a non-binding term sheet for licensing of NLS intellectual propertyNLS has secured an additional bridge loan through...
Biomea Fusion Abstract “BMF-219: A Novel Therapeutic Agent to Reestablish Functional Beta Cells and Provide Long-term Glycemic Control” Selected as One of Six Oral Presentations at 21st World Congress Insulin Resistance, Diabetes & Cardiovascular Disease
BMF-219 is an investigational novel covalent menin inhibitor designed to regenerate insulin-producing beta cells with the aim to cure diabetesNew...
Harbour Coca Approved to Commercially Distribute Coca Leaf Internationally Following Landmark Trade Agreement with Peruvian State-Run Coca Leaf Producer
Harbour Becomes Authorized Agent of Coca Globally, Permitting the Distribution of Ethically Sourced, High-Quality Coca Leaf For Emerging OpportunitiesToronto, Ontario--(Newsfile...
Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Toronto, Ontario--(Newsfile Corp. - November 16, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
Poolbeg Pharma PLC Announces POLB 001 LPS Trial Data to be Presented at IUIS
POLB 001 - a potential blockbuster immunomodulatorLONDON, UK / ACCESSWIRE / November 16, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or...